Company news
Cizzle Biotechnology Holdings PLC news in 2026
Cizzle Biotechnology Holdings PLC's news releases, calls and decks from 2026, newest first.
Holding(s) in Company
November 2, 2026
£500,000 Subscription, conversion of loan notes
October 26, 2026
Cizzle presents at SYNLAB Innovation Symposium
October 23, 2026
Cizzle Shortlisted for One Nucleus Award 2026
October 19, 2026
Update on Launch of Lung Cancer Test in USA
October 15, 2026
Interim Results
September 30, 2026
Laboratory Expansion to Accelerate Sales in USA
August 3, 2026
Update on Sales in USA
July 22, 2026
Half Year Operational Update
July 15, 2026
Change of Corporate Broker
June 30, 2026
CIZ1B Test Approved For Clinical Use in USA
June 16, 2026
Patent Granted in USA
June 12, 2026
Issue of Options, Salary Waivers, Incentive Plan
May 7, 2026
Conversion of Convertible Loan Notes
May 6, 2026
Final results for the year ended 31 December 2025
April 30, 2026
£250,000 Funding Facility
April 2, 2026
Progress on Launch of Biomarker Test in USA
February 23, 2026
Patent Granted in Canada
February 4, 2026